La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
KONE Oyj Croissance future
Future contrôle des critères 3/6
KONE Oyj devrait augmenter ses bénéfices et son chiffre d'affaires de 6.2% et de 3.5% par an respectivement. Le BPA devrait croître de de 6.2% par an. Le rendement des capitaux propres devrait être 38.1% dans 3 ans.
Informations clés
6.2%
Taux de croissance des bénéfices
6.2%
Taux de croissance du BPA
Machinery croissance des bénéfices | 8.9% |
Taux de croissance des recettes | 3.5% |
Rendement futur des capitaux propres | 38.2% |
Couverture par les analystes | Good |
Dernière mise à jour | 23 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Risks To Shareholder Returns Are Elevated At These Prices For KONE Oyj (HEL:KNEBV)
Aug 19KONE Oyj (HEL:KNEBV) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
Jul 22Does KONE Oyj (HEL:KNEBV) Have A Healthy Balance Sheet?
Jun 21Estimating The Intrinsic Value Of KONE Oyj (HEL:KNEBV)
May 23Investors Should Be Encouraged By KONE Oyj's (HEL:KNEBV) Returns On Capital
May 09KONE Oyj's (HEL:KNEBV) Price Is Out Of Tune With Earnings
Apr 24These 4 Measures Indicate That KONE Oyj (HEL:KNEBV) Is Using Debt Safely
Mar 13KONE Oyj (HEL:KNEBV) Is Due To Pay A Dividend Of €1.75
Feb 01A Look At The Fair Value Of KONE Oyj (HEL:KNEBV)
Dec 31These 4 Measures Indicate That KONE Oyj (HEL:KNEBV) Is Using Debt Safely
Nov 30Returns On Capital At KONE Oyj (HEL:KNEBV) Have Stalled
Oct 04Estimating The Fair Value Of KONE Oyj (HEL:KNEBV)
Sep 19We Think KONE Oyj (HEL:KNEBV) Can Manage Its Debt With Ease
Aug 20Returns At KONE Oyj (HEL:KNEBV) Appear To Be Weighed Down
Jun 25Does This Valuation Of KONE Oyj (HEL:KNEBV) Imply Investors Are Overpaying?
Jun 11These 4 Measures Indicate That KONE Oyj (HEL:KNEBV) Is Using Debt Reasonably Well
May 15Is KONE Oyj (HEL:KNEBV) Expensive For A Reason? A Look At Its Intrinsic Value
Mar 13Most Shareholders Will Probably Agree With KONE Oyj's (HEL:KNEBV) CEO Compensation
Feb 22We Think KONE Oyj (HEL:KNEBV) Can Stay On Top Of Its Debt
Feb 02Returns On Capital At KONE Oyj (HEL:KNEBV) Paint A Concerning Picture
Jan 15Estimating The Fair Value Of KONE Oyj (HEL:KNEBV)
Nov 28Here's Why KONE Oyj (HEL:KNEBV) Can Manage Its Debt Responsibly
Oct 27The Returns On Capital At KONE Oyj (HEL:KNEBV) Don't Inspire Confidence
Oct 12Is There An Opportunity With KONE Oyj's (HEL:KNEBV) 40% Undervaluation?
Aug 27Here's Why KONE Oyj (HEL:KNEBV) Can Manage Its Debt Responsibly
Jul 28Returns At KONE Oyj (HEL:KNEBV) Appear To Be Weighed Down
Jul 11An Intrinsic Calculation For KONE Oyj (HEL:KNEBV) Suggests It's 23% Undervalued
May 25Is KONE Oyj (HEL:KNEBV) Using Too Much Debt?
Apr 25Return Trends At KONE Oyj (HEL:KNEBV) Aren't Appealing
Apr 10It's Unlikely That KONE Oyj's (HEL:KNEBV) CEO Will See A Huge Pay Rise This Year
Feb 22Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 12,050 | 1,199 | 1,328 | 1,580 | 16 |
12/31/2025 | 11,549 | 1,110 | 1,277 | 1,529 | 20 |
12/31/2024 | 11,157 | 1,020 | 1,103 | 1,396 | 19 |
6/30/2024 | 10,929 | 981 | 925 | 1,114 | N/A |
3/31/2024 | 10,964 | 945 | 920 | 1,090 | N/A |
12/31/2023 | 10,952 | 926 | 980 | 1,128 | N/A |
9/30/2023 | 11,054 | 925 | 566 | 737 | N/A |
6/30/2023 | 11,302 | 917 | 679 | 826 | N/A |
3/31/2023 | 11,021 | 829 | 594 | 713 | N/A |
12/31/2022 | 10,907 | 775 | 430 | 532 | N/A |
9/30/2022 | 10,762 | 778 | 975 | 1,052 | N/A |
6/30/2022 | 10,374 | 800 | 980 | 1,052 | N/A |
3/31/2022 | 10,630 | 951 | 1,290 | 1,380 | N/A |
12/31/2021 | 10,514 | 1,014 | 1,488 | 1,585 | N/A |
9/30/2021 | 10,369 | 1,022 | 1,277 | 1,409 | N/A |
6/30/2021 | 10,346 | 1,023 | 1,439 | 1,568 | N/A |
3/31/2021 | 10,067 | 980 | 1,577 | 1,673 | N/A |
12/31/2020 | 9,939 | 939 | 1,462 | 1,550 | N/A |
9/30/2020 | 10,002 | 936 | 1,517 | 1,590 | N/A |
6/30/2020 | 9,973 | 922 | 1,391 | 1,475 | N/A |
3/31/2020 | 9,981 | 916 | 1,119 | 1,224 | N/A |
12/31/2019 | 9,982 | 931 | 1,172 | 1,270 | N/A |
9/30/2019 | 9,741 | 882 | 1,080 | 1,272 | N/A |
6/30/2019 | 9,472 | 851 | 954 | 1,105 | N/A |
3/31/2019 | 9,262 | 838 | 1,035 | 1,163 | N/A |
12/31/2018 | 9,071 | 841 | 856 | 970 | N/A |
9/30/2018 | 8,934 | 842 | 819 | 903 | N/A |
6/30/2018 | 8,855 | 878 | 796 | 898 | N/A |
3/31/2018 | 8,861 | 920 | N/A | 829 | N/A |
12/31/2017 | 8,797 | 956 | N/A | 964 | N/A |
9/30/2017 | 9,084 | 1,022 | N/A | 1,003 | N/A |
6/30/2017 | 9,044 | 1,033 | N/A | 1,109 | N/A |
3/31/2017 | 8,979 | 1,042 | N/A | 1,167 | N/A |
12/31/2016 | 8,784 | 1,024 | N/A | 1,178 | N/A |
9/30/2016 | 8,753 | 1,091 | N/A | 1,297 | N/A |
6/30/2016 | 8,767 | 1,083 | N/A | 1,354 | N/A |
3/31/2016 | 8,705 | 1,070 | N/A | 1,466 | N/A |
12/31/2015 | 8,647 | 1,032 | N/A | 1,447 | N/A |
9/30/2015 | 8,251 | 873 | N/A | 1,313 | N/A |
6/30/2015 | 7,945 | 825 | N/A | 1,259 | N/A |
3/31/2015 | 7,584 | 764 | N/A | 1,077 | N/A |
12/31/2014 | 7,335 | 756 | N/A | 1,124 | N/A |
9/30/2014 | 7,202 | 734 | N/A | 1,012 | N/A |
6/30/2014 | 7,063 | 728 | N/A | 1,003 | N/A |
3/31/2014 | 6,976 | 719 | N/A | 1,052 | N/A |
12/31/2013 | 6,933 | 702 | N/A | 1,022 | N/A |
9/30/2013 | 6,757 | 699 | N/A | 1,048 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de KNEBV ( 6.2% par an) est supérieure au taux d'épargne ( 1.2% ).
Bénéfices vs marché: Les bénéfices de KNEBV ( 6.2% par an) devraient croître plus lentement que le marché Finnish ( 16.3% par an).
Croissance élevée des bénéfices: Les bénéfices de KNEBV devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de KNEBV ( 3.5% par an) devrait croître plus rapidement que le marché Finnish ( 2.5% par an).
Croissance élevée des revenus: Le chiffre d'affaires de KNEBV ( 3.5% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de KNEBV devrait être élevé dans 3 ans ( 38.1 %)